News | April 26, 2013

Tomosynthesis may improve detection in dense breasts

April 26, 2013 — Two-dimensional plus 3-D breast imaging increases cancer detection rates by 11 percent, and could be particularly useful in detecting cancer in women with dense breasts, a new clinical study suggests.

Researchers at Yale University Smilow Cancer Hospital in New Haven, Conn., reviewed the screening mammograms of 14,684 patients. Forty-two cancers were found in 8,769 patients who had only 2-D imaging (a cancer detection rate of 4.8 per 1,000), said Jaime Geisel, a lead author of the study. Thirty-two cancers were found in the group that had 2-D plus 3-D (tomosynthesis) imaging, for a cancer detection rate of 5.4 per 1,000, said Geisel. The percent of invasive and intraductal cancers detected among the two groups was similar, she said.

In addition to the improved cancer detection rate, "of the patients who had cancer detected with 3-D, 54 percent had dense breasts. Of the patients who had cancer detected with 2-D only, 21 percent had dense breasts. This suggests better performance of the 3-D in dense breast tissue given 3-D was offered to patients regardless of breast density or risk factors," Geisel said.

Geisel noted that the majority of screening mammograms at her facility now include 3-D imaging.

"I am hopeful that my study will help raise awareness among physicians as well as women undergoing breast cancer screening," she said. Additional research needs to be done; "We recognize the numbers are still too small to draw significant conclusions, but the data is compelling," she said.

Geisel presented her study at the ARRS annual meeting on April 19 in Washington, D.C.


Related Content

News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
Subscribe Now